艾德(de)生(sheng)物(wu)（300685）公(gong)(gong)(gong)告，廈(sha)門艾德(de)生(sheng)物(wu)醫藥科(ke)技股(gu)份有限公(gong)(gong)(gong)司(si)與AstraZenecaUKLimited的(de)子(zi)公(gong)(gong)(gong)司(si)KuDOSPharmaceuticalsLimited簽署(shu)了合(he)作協議。公(gong)(gong)(gong)司(si)自(zi)主(zhu)研發的(de)人類(lei)同源重組修復缺陷(xian)(HRD)檢測產品(pin)(pin)將(jiang)作為阿斯利康PARP抑制(zhi)劑利普(pu)卓(奧拉(la)帕利)卵(luan)巢癌適(shi)應癥(zheng)在(zai)中國的(de)伴(ban)隨診斷，并將(jiang)積極推進HRD檢測產品(pin)(pin)在(zai)國家藥品(pin)(pin)監督(du)管理局(ju)的(de)注冊審批(pi)。